Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2011

01-04-2011 | Stanford Multidisciplinary Seminars

War and Peace” with Barrett’s Esophagus

Authors: George Triadafilopoulos, Charles M. Lombard, Blair A. Jobe

Published in: Digestive Diseases and Sciences | Issue 4/2011

Login to get access

Excerpt

An athletic, intelligent, Caucasian male electrical engineer turned Silicon Valley venture capitalist, who was born in 1943, is managed primarily in the outpatient gastroenterology clinic of Stanford University Medical Center over a 30-year period (1980–2010). …
Literature
1.
go back to reference Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med. 2008;359:1700–1707.PubMedCrossRef Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med. 2008;359:1700–1707.PubMedCrossRef
2.
go back to reference Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology. 2002;122:633–640.PubMedCrossRef Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology. 2002;122:633–640.PubMedCrossRef
3.
go back to reference Atwood SJ. Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3 year experience. J Gastrointestinal Surg. 2008;12:1646–1654.CrossRef Atwood SJ. Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3 year experience. J Gastrointestinal Surg. 2008;12:1646–1654.CrossRef
4.
go back to reference Fitzgerald RC, Omary MB, Triadafilopoulos G. Dynamic effects of acid on Barrett’s esophagus: an ex vivo proliferation and differentiation model. J Clin Invest. 1996;98:2120–2128.PubMedCrossRef Fitzgerald RC, Omary MB, Triadafilopoulos G. Dynamic effects of acid on Barrett’s esophagus: an ex vivo proliferation and differentiation model. J Clin Invest. 1996;98:2120–2128.PubMedCrossRef
5.
go back to reference Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology. 1999;117:327–335.PubMedCrossRef Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology. 1999;117:327–335.PubMedCrossRef
7.
go back to reference Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol. 2009;104:1356–1362.PubMedCrossRef Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol. 2009;104:1356–1362.PubMedCrossRef
8.
go back to reference Wang KK, Sampliner RE. Practice parameters committee of the American college of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.PubMedCrossRef Wang KK, Sampliner RE. Practice parameters committee of the American college of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.PubMedCrossRef
10.
go back to reference Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett’s esophagus. Dig Dis Sci. 2010;55:1918–1931.PubMedCrossRef Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett’s esophagus. Dig Dis Sci. 2010;55:1918–1931.PubMedCrossRef
11.
go back to reference Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8:23–29.PubMedCrossRef Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8:23–29.PubMedCrossRef
12.
go back to reference Triadafilopoulos G. Blitzkrieg for Barrett’s esophagus containing early neoplasia. Clin Gastroenterol Hepatol. 2010;8:7–9.PubMedCrossRef Triadafilopoulos G. Blitzkrieg for Barrett’s esophagus containing early neoplasia. Clin Gastroenterol Hepatol. 2010;8:7–9.PubMedCrossRef
13.
go back to reference Gilbert S, Jobe BA. Surgical therapy for Barrett’s esophagus with high-grade dysplasia and early esophageal carcinoma. Surg Oncol Clin N Am. 2009;18:523–531.PubMedCrossRef Gilbert S, Jobe BA. Surgical therapy for Barrett’s esophagus with high-grade dysplasia and early esophageal carcinoma. Surg Oncol Clin N Am. 2009;18:523–531.PubMedCrossRef
14.
go back to reference Chang AC, Lee JS, Sawicki KT, Pickens A, Orringer MB. Outcomes after esophagectomy in patients with prior anti-reflux or hiatal hernia surgery. Ann Thorac Surg. 2010;89:1015–1021.PubMedCrossRef Chang AC, Lee JS, Sawicki KT, Pickens A, Orringer MB. Outcomes after esophagectomy in patients with prior anti-reflux or hiatal hernia surgery. Ann Thorac Surg. 2010;89:1015–1021.PubMedCrossRef
Metadata
Title
“War and Peace” with Barrett’s Esophagus
Authors
George Triadafilopoulos
Charles M. Lombard
Blair A. Jobe
Publication date
01-04-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1490-0

Other articles of this Issue 4/2011

Digestive Diseases and Sciences 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.